首页> 美国卫生研究院文献>Translational Gastroenterology and Hepatology >Efficacy and safety of APT036 versus simethicone in the treatment of functional bloating: a multicentre randomised double-blind parallel group clinical study

【2h】

Efficacy and safety of APT036 versus simethicone in the treatment of functional bloating: a multicentre randomised double-blind parallel group clinical study

机译：APT036与二甲硅油治疗功能性腹胀的疗效和安全性：多中心随机双盲平行组临床研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundBloating is a common symptom reported by around 16% to 31% of the general population. Functional bloating is diagnosed in patients with recurrent symptoms of bloating who do not meet the diagnostic criteria of irritable bowel syndrome or other functional gastrointestinal disorders.

机译：背景腹胀是一种常见症状，约占总人口的16％至31％。功能性腹胀被诊断为不符合肠易激综合征或其他功能性胃肠道疾病诊断标准的复发性腹胀症状患者。

著录项

期刊名称 Translational Gastroenterology and Hepatology
作者
Ovidiu Burta; Claudia Iacobescu; Radu Bogdan Mateescu; Tudor Nicolaie; Nicoleta Tiuca; Corina Silvia Pop;
展开▼
作者单位

展开▼
年(卷),期 2018(3),-1
年度 2018
页码 72
总页数 23
原文格式 PDF
正文语种
中图分类免疫学;
关键词

相似文献

外文文献
中文文献
专利

1. A Multicentre, Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Sirukumab in the Treatment of Giant Cell Arteritis [J] . Wolfgang A. Schmidt, Bhaskar Dasgupta, Raashid Luqmani, Rheumatology and Therapy . 2020,第4期

机译：多期式，随机，双盲，安慰剂控制，并联研究，以评估Sirukumab在治疗巨细胞动脉炎的疗效和安全性
2. Efficacy and safety of So-Cheong-Ryong-Tang in treatment of perennial allergic rhinitis: study protocol for a double-blind, randomised, parallel-group, multicentre trial [J] . Inhwa Choi, Younghee Yun, Youme Ko, BMJ Open . 2017,第9期

机译：So-Cheong-Ryong-Tang治疗多年生变应性鼻炎的功效和安全性：一项双盲，随机，平行分组，多中心试验的研究方案
3. Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial [J] . Sorli Christopher, Harashima Shin-ichi, Tsoukas George M., The lancet. Diabetes & endocrinology. . 2017,第4期

机译：患有2型糖尿病患者的一次每周半蛋白质单药治疗的疗效和安全性（持续1）：双盲，随机，安慰剂控制，平行群，跨国，多元相3A试验
4. Verapamil is an effective prophylactic for cluster headache: results of a double-blind multicentre study versus placebo [C] . Massimo Leone, Domenico D Amico, Angelo Attanasio, International Headache Research Seminar . 1999

机译：维拉帕米是一种有效的群集头痛的预防性：双盲多期面研究的结果与安慰剂
5. A Phase 1B, Double-blind, Placebo-controlled, Parallel-group, Multi-dose Study of the Pharmacodynamics of NGM282 on Colonic Transit, Bile Acid Homeostasis and Fecal Fat in Subjects with Functional Constipation [D] . Oduyebo, Ibironke. 2018

机译：1B，双盲，安慰剂控制，并行组，NGM282对结肠转运，胆汁酸痛和患者功能性便秘的粪便脂肪的药物动力学的多剂量研究
6. A Multicentre Randomised Double-Blind Placebo-Controlled Parallel-Group Study to Evaluate the Efficacy and Safety of Sirukumab in the Treatment of Giant Cell Arteritis [O] . Wolfgang A. Schmidt, Bhaskar Dasgupta, Raashid Luqmani, 2020

机译：多期式随机双盲安慰剂控制并联研究以评估Sirukumab在治疗巨细胞动脉炎的疗效和安全性
7. Efficacy and safety of two doses of S 90098 (1 and 2 mg/day), sublingual formulation for 8 weeks in out-patients with major depressive disorder: An 8-week randomised, double-blind, fixed dose, international, multicentre, placebo-controlled study with parallel groups, followed by an extension double-blind treatment period for 16 weeks [O] . Frédéric Rouillon 2012

机译：两剂S 90098（1和2毫克/天）的疗效和安全性，舌下制剂8周，患有主要抑郁症的患者：8周随机化，双盲，固定剂量，国际，多期，安慰剂 - 与平行组进行控制，然后进行延伸双盲治疗期16周

Efficacy and safety of APT036 versus simethicone in the treatment of functional bloating: a multicentre randomised double-blind parallel group clinical study

摘要

著录项

相似文献

相关主题

期刊订阅